A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation

被引：0
|
作者：
Masahiko Fukatsu
Takenobu Murakami
Hiroshi Ohkawara
Shunichi Saito
Kazuhiko Ikeda
Suguru Kadowaki
Itaru Sasaki
Mari Segawa
Tomoko Soeda
Akihiko Hoshi
Hiroshi Takahashi
Akiko Shichishima-Nakamura
Kazuei Ogawa
Yoshihiro Sugiura
Hitoshi Ohto
Yasuchika Takeishi
Takayuki Ikezoe
Yoshikazu Ugawa
机构：
[1] Fukushima Medical University,Department of Neurology
[2] Fukushima Medical University,Department of Hematology
[3] Fukushima Medical University,Department of Blood Transfusion and Transplantation Immunology
[4] Fukushima Medical University,Department of Cardiovascular Medicine
[5] Fukushima Medical University,Fukushima Global Medical Science Center, Advanced Clinical Research Center
来源：
BMC Neurology | / 17卷
关键词：
Myasthenia gravis; Hematopoietic cell transplantation; Graft-versus-host disease; Regulatory T cells; Rituximab; Anti-acetylcholine receptor antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] B-CELL AND T-CELL INVOLVEMENT IN ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-FORMATION IN MYASTHENIA-GRAVIS
    SHINOMIYA, N
    YATA, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1981, 46 (02): : 277 - 285
  • [42] GM-CSF-Induced Regulatory T cells Selectively Inhibit Anti-Acetylcholine Receptor-Specific Immune Responses in Experimental Myasthenia Gravis
    Sheng, Jianrong
    Prabahakar, Bellur
    Meriggioli, Matthew
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [43] Efficacy and safety of eculizumab in patients with treatmentrefractory anti-acetylcholine receptor antibody-positive generalised myasthenia gravis previously treated with rituximab
    Patti, Francesco
    Mozaffar, Tahseen
    Yountz, Marcus
    O'Brien, Fanny
    Siddiqi, Zaeem
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [44] ACETYLCHOLINE-RECEPTOR ANTIBODY-PRODUCTION BY BONE-MARROW CELLS IN A PATIENT WITH MYASTHENIA-GRAVIS
    FUJII, Y
    MONDEN, Y
    HASHIMOTO, J
    NAKAHARA, K
    KAWASHIMA, Y
    NEUROLOGY, 1985, 35 (04) : 577 - 579
  • [45] GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis
    Sheng, Jian Rong
    Muthusamy, Thiruppathi
    Prabhakar, Bellur S.
    Meriggioli, Matthew N.
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 240 : 65 - 73
  • [46] Eculizumab versus rituximab for refractory anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: a single-center experience
    Durmus, H.
    Cakar, A.
    Parman, Y.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [47] SERIAL ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY TITERS IN PATIENTS WITH MYASTHENIA-GRAVIS - EFFECTS OF CORTICOSTEROID-THERAPY
    SEYBOLD, ME
    LINDSTROM, JM
    MUSCLE & NERVE, 1978, 1 (04) : 343 - 343
  • [48] Effect of Buzhong Yiqi decoction on anti-acetylcholine receptor antibody and clinical status in juvenile ocular myasthenia gravis
    Li, Jiaduo
    Qi, Guoyan
    Liu, Yaling
    MEDICINE, 2021, 100 (44)
  • [49] TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis
    Franciotta, D
    Martino, G
    Brambilla, E
    Zardini, E
    Locatelli, V
    Bergami, A
    Tinelli, C
    Desina, G
    Cosi, V
    CLINICAL CHEMISTRY, 1999, 45 (03) : 400 - 405
  • [50] A SOLID-PHASE ENZYME-IMMUNOASSAY FOR ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY IN MYASTHENIA-GRAVIS PATIENTS
    KOBAYASHI, N
    SUGITA, H
    TERADA, E
    GHODA, A
    OKUDAIRA, H
    OGITA, T
    MIYAMOTO, T
    JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 73 (02) : 267 - 272
12345